Submissions from 2023
Take-Home Naloxone and Opioid Prescribing Patterns by Provider Specialty Type in Chronic Pain Patients: A Retrospective Study (2023, May) Poster Presented at the American Socierty for Pain and Neurology, D Ile, Alyx Lesko, and See all authors in comments
Patient Perception of Education, Care Coordination, and Psychological Distress After Developing Facial Paralysis: A Qualitative Study., Natalie R Kenton, Merai Estafanous, Kyohei Itamura, Ania Filus, Shanthi Gowrinathan, Neil A Martin, Walavan Sivakumar, Garni Barkhoudarian, Patrick J Byrne, and Amit Kochhar
Poster Presented at the International Stroke Conference, T Lowenkopf, Alyx Lesko, and See all authors in comments
Multicenter Flow Diversion for Intracranial Aneurysms: Intracranial Hemorrhage & Thromboembolic Complications In A Multi-Center Cohort of 200 Patients, R Meister, Alyx Lesko, and See all authors in comments
Multicenter Flow Diversion in 200 individuals for treatment of intracranial aneurysms, R Meister, Alyx Lesko, and See all authors in comments
Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine, R Meng, Will Redmond, Carlo Bifulco, Rachel Sanborn, RB Bell, Walter Urba, Rom Leidner, Brian Piening, Bernard Fox, and See full list of authors in comments
PD-1 expression on tumor-infiltrating T-lymphocytes as determinant of the head and neck cancer tumor immune microenvironment rather than anatomical site, T Muijlwijk, Bernard Fox, and See full list of authors in comments
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial., Tulika Ranjan, Soma Sengupta, Michael J Glantz, Richard M Green, Alexander Yu, Dawit Aregawi, Rekha Chaudhary, Ricky Chen, Mario Zuccarello, Christine Lu-Emerson, Hugh D Moulding, Neil Belman, Jon Glass, Aaron Mammoser, Mark Anderson, Jagan Valluri, Nicholas Marko, Jason Schroeder, Steven Jubelirer, Frances Chow, Pier Paolo Claudio, Anthony M Alberico, Seth T Lirette, Krista L Denning, and Candace M Howard
Robot-Assisted Transcranial Doppler Versus Transthoracic Echocardiography for Right to Left Shunt Detection., Mark N Rubin, Ruchir Shah, Thomas Devlin, Teddy S Youn, Michael F Waters, John J Volpi, Aaron Stayman, Colleen Douville, Ted Lowenkopf, Georgios Tsivgoulis, and Andrei V Alexandrov
Hybrid repair of an innominate artery pseudoaneurysm after blunt traumatic injury in a bovine arch., Keyuree Satam, Sabina Sorondo, Michael Paisley, and Venita Chandra
Impact of Patient Characteristics and COVID 19 on Last Known Well to Arrival, T Singh, Alyx Lesko, and See all authors in comments
Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE)., Kyle Smoot, Horia Marginean, Tiffany Gervasi-Follmar, Chiayi Chen, Pavle Repovic, and Stanley Cohan
Facial nerve palsy: An early sign of COVID-19., Michael Somero, Elisa Akagi, and Ashish Bhargava
Maternal Group B Streptococcus Prophylaxis Improvement using an Electronic Medical Record Dynamic Order Set., Mark Tomlinson, Rachael Baker, Jennifer Ulrich, Maulin P. Shah, Horia Marginean, and Stephen Girolami
A Retrospective Study Comparing Clinical Outcomes For Thrombectomy-treated Patients With Large Vessel Occlusion Who Met Or Did Not Meet AHA/ASA Eligibility Criteria, J Wallace, Alyx Lesko, and See all authors in comments
Retrospective safety study of low severity intracranial hemorrhage patients, evaluating a care protocol aimed at keeping patients at spoke hospitals, J Wallace, Alyx Lesko, and See all authors in comments
Using CD39/CD103 to Isolate Tumor-Reactive CD8 TIL: Bench to Bedside, AD Weinberg
Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM., Mitzi J Williams, Lilyana Amezcua, Angel Chinea, Stanley Cohan, Annette Okai, Darin T Okuda, Wendy Vargas, Nick Belviso, Ivan Božin, Xiaotong Jiang, James B Lewin, Jennifer Lyons, Changyu Shen, Sarah M England, and Nydjie Grimes
Submissions from 2022
Vessel Wall Enhancement in Unilateral Primary Angiitis of the Central Nervous System., Adrian Budhram, Shailee S Shah, Christopher P Wood, Michael A Lane, Kyle E Smoot, and Brian G Weinshenker
Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION-A 2-Year, Multicenter, Observational, Cohort Study., Helmut Butzkueven, Paul S Giacomini, Stanley Cohan, Tjalf Ziemssen, Daniel Sienkiewicz, Ying Zhang, Yvonne Geissbühler, Diego Silva, Davorka Tomic, Harald Kropshofer, and Maria Trojano
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis., Stanley Cohan, Ralph H B Benedict, Bruce A C Cree, John DeLuca, Le H Hua, and Jerold Chun
Functional status at 30 and 90 days after mild ischaemic stroke., Hannah Gardener, Leo A Romano, Eric E Smith, Iszet Campo-Bustillo, Yosef Khan, Sofie Tai, Nikesha Riley, Ralph L Sacco, Pooja Khatri, Heather M Alger, Brian Mac Grory, Deepak Gulati, Navdeep S Sangha, Karin E Olds, Curtis G Benesch, Adam G Kelly, Scott S Brehaut, Amit Kansara, Lee H Schwamm, and Jose G Romano
Video game rehabilitation for outpatient stroke (VIGoROUS): A multi-site randomized controlled trial of in-home, self-managed, upper-extremity therapy., Lynne V Gauthier, Deborah S Nichols-Larsen, Gitendra Uswatte, Nancy Strahl, Marie Simeo, Rachel Proffitt, Kristina Kelly, Roger Crawfis, Edward Taub, David Morris, Linda Pax Lowes, Victor Mark, and Alexandra Borstad
Perceived utility of electrodiagnostic testing in critical illness myopathy and polyneuropathy: A survey of intensive care unit providers., Michael Isfort, Bryan J McVerry, Lori Shutter, Minji Kim, and David Lacomis
A Case Report: Splenium of the Corpus Callosum Infarct Associated With COVID-19., David A Karp, Gabriel Beaudoin, and Robert A Egan
Tenecteplase implementation for ischemic stroke at a large tertiary medical center, Laura Kays, Bryce Winn, and Aimee Doyle
Advancing Care and Outcomes for African American Patients With Multiple Sclerosis., Annette F Okai, Annette M Howard, Mitzi J Williams, Justine Brink, Chiayi Chen, tamela stuchiner, Elizabeth Baraban, Grace Jeong, and Stanley Cohan
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder., Jonathan D Santoro, Rebecca Partridge, Runi Tanna, Dania Pagarkar, Mellad Khoshnood, Mustafa Rehmani, Ryan M Kammeyer, Grace Y Gombolay, Kristen Fisher, Allison Conravey, Jane El-Dahr, Alison Christy, Lina Patel, Melanie A Manning, Heather Van Mater, Michael S Rafii, and Eileen A Quinn
Assessment and Diagnosis of Down Syndrome Regression Disorder: International Expert Consensus., Jonathan D Santoro, Lina Patel, Ryan Kammeyer, Robyn A Filipink, Grace Y Gombolay, Kathleen M Cardinale, Diego Real de Asua, Shahid Zaman, Stephanie L Santoro, Sammer M Marzouk, Mellad Khoshnood, Benjamin N Vogel, Runi Tanna, Dania Pagarkar, Sofia Dhanani, Maria Del Carmen Ortega, Rebecca Partridge, Maria A Stanley, Jessica S Sanders, Alison Christy, Elise M Sannar, Ruth Brown, Andrew A McCormick, Heather Van Mater, Cathy Franklin, Gordon Worley, Eileen A Quinn, George T Capone, Brian Chicoine, Brian G Skotko, and Michael S Rafii
An Evaluation of Oral Anticoagulation Initiation after Ischemic Stroke in Patients with Atrial fibrillation/Atrial Flutter at Hospital Discharge, Jessica Zhao, Meri Slavica, Vanessa Jenkins, and Natalie Swearingen
Submissions from 2021
Comparing Ischemic Stroke Volumes Across a Large Multi-State Health System Prior to and During the Covid-19 Pandemic, Elizabeth Baraban, T Stuchiner, and C Moreno
Adding Incapacity to Injury: A Case of Trauma and Central Cord Syndrome, Christopher Bender and Jesse Powell
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide., Stanley Cohan, Tiffany Gervasi-Follmar, Aneesh Kamath, Vineetha Kamath, Chiayi Chen, Kyle Smoot, Elizabeth Baraban, and Keith Edwards
Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison., Stanley Cohan, Jinender Kumar, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic, and Tom Tencer
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)., Stanley L Cohan, Barry A Hendin, Anthony T Reder, Kyle Smoot, Robin Avila, Jason P Mendoza, and Bianca Weinstock-Guttman
Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis., Stanley Cohan, Tom Tencer, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic, and Jinender Kumar
Differences in characteristics and care among stroke patients with documented substance use, L Corless, Alyx Lesko, T Stuchiner, C Garvin, and Elizabeth Baraban
Outcomes for Stroke Patients with Documented Substance Use as Compared to Those without Substance Use, L Corless, T Stuchiner, Alyx Lesko, C Garvin, and Elizabeth Baraban
Healthcare utilization and cost outcomes for a multicenter first seizure and new onset epilepsy clinic., Emily R Hudson, Alexandra Lesko, Lindsay Lucas, Elizabeth Baraban, and Evan J Fertig
Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination., Ludwig Kappos, Stanley Cohan, Douglas L Arnold, Randy R Robinson, Joan Holman, Sami Fam, Becky Parks, Shan Xiao, and Wanda Castro-Borrero
Is the Symbol Digit Modalities Test a useful outcome in secondary progressive multiple sclerosis?, Marcus W Koch, Jop Mostert, P Repovic, J D Bowen, Bernard Uitdehaag, and Gary Cutter
Assessing the Clinical Characteristics of Non-Valvular Atrial Fibrillation Patients Who are Uncontrolled on Warfarin, T Lowenkopf, T Stuchiner, L Corless, O Hartaigh, C Wang, and Elizabeth Baraban
Safety of the APOLLO Onyx delivery microcatheter for embolization of brain arteriovenous malformations: results from a prospective post-market study., Philip M Meyers, Johanna T Fifi, Kevin M Cockroft, Timothy R Miller, Curtis A Given, Ali R Zomorodi, Bharathi D Jagadeesan, Maxim Mokin, Peter Kan, Tom L Yao, Orlando Diaz, Daniel Huddle, Richard J Bellon, Joshua Seinfeld, Adam J Polifka, David Fiorella, Rohan V Chitale, Peter Kvamme, Jay T Morrow, Justin Singer, Ajay K Wakhloo, Ajit S Puri, Vivek Deshmukh, Ricardo A Hanel, L Fernando Gonzalez, Henry H Woo, and Mohammad Ali Aziz-Sultan
Abstract P77: Acute Stroke Trends and Outcomes During the COVID-19 Pandemic in a Multi-System Hospital System in the Western US, Renee Ovando, Natalie Swearingen, Tamela Stuchiner, Leslie Corless, Crystal Ann Moreno, John Zurasky, Jason Tarpley, Radoslav Raychev, and Elizabeth Baraban
Anticoagulation Therapy Reduces Recurrent Stroke in Embolic Stroke of Undetermined Source Patients With Elevated Coagulation Markers or Severe Left Atrial Enlargement., Kishan Patel, Elio Mikhael, Michael Liu, Srikant Rangaraju, Deandra Ellis, Alexander Duncan, Samir Belagaje, Trina Belair, Laura Henriquez, and Fadi Nahab
Impact of Center Certification Status on Acute Stroke Care Within A Multi-Hospital System in the Western United States, R Raychev, C Moreno, L Corless, J Tarpley, J Zurasky, Y Loh, and Elizabeth Baraban
Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS., Jose G Romano, Hannah Gardener, Iszet Campo-Bustillo, Yosef Khan, Sofie Tai, Nikesha Riley, Eric E Smith, Ralph L Sacco, Pooja Khatri, Heather M Alger, Brian Mac Grory, Deepak Gulati, Navdeep S Sangha, Jeffrey M Craig, Karin E Olds, Curtis G Benesch, Adam G Kelly, Scott S Brehaut, Amit C Kansara, Lee H Schwamm, and MaRISS Investigators
Frequency and Prognostic Significance of Clinical Fluctuations Before Hospital Arrival in Stroke., Jose G Romano, Hannah Gardener, Eric E Smith, Iszet Campo-Bustillo, Yosef Khan, Sofie Tai, Nikesha Riley, Ralph L Sacco, Pooja Khatri, Heather M Alger, Brian Mac Grory, Deepak Gulati, Navdeep S Sangha, Karin E Olds, Curtis G Benesch, Adam G Kelly, Scott S Brehaut, Amit Kansara, and Lee H Schwamm
Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study., Kyle Smoot, Chiayi Chen, Tamela Stuchiner, Lindsay Lucas, Lois Grote, and Stanley Cohan
Genetic deletion of Polo-like kinase 2 reduces alpha-synuclein serine-129 phosphorylation in presynaptic terminals but not Lewy bodies., Leah J Weston, Teresa L Stackhouse, Kateri Spinelli, Sydney W Boutros, Elizabeth P Rose, Valerie R Osterberg, Kelvin C Luk, Jacob Raber, Tamily A Weissman, and Vivek K Unni
Submissions from 2020
Thrombectomy Techniques And Patient Characteristics Associated With Complete Tici 3 Reperfusion After Stroke Thrombectomy, Elizabeth Baraban, T Stuchiner, R Ovando, R Darflinger, S Hou, D Kelly, G Teitelbaum, T Ambooj, and Jason Tarpley
Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article., Stanley Cohan, Elisabeth Lucassen, Kyle E Smoot, Justine Brink, and Chiayi Chen
Improved Urinary Continence for Stroke Survivors in Inpatient Rehab, Lauren Logan, Evelyn Laws, Charmika Schuster, Emily Sharawara, Steven Anderson, Shireen Hussien, Robin Nelson, Ann Sandstedt, Nadine Tranquilla, Natalie Swearingen, and Diane Clark
The NEALS primary lateral sclerosis registry., Sabrina Paganoni, Fabiola De Marchi, James Chan, Sara K Thrower, Nathan P Staff, Neil Datta, Yaz Y Kisanuki, Vivian Drory, Christina Fournier, Erik P Pioro, Stephen A Goutman, Nazem Atassi, NEALS PLS Registry Study Group, Maryangel Jeon, Sarah Caldwell, Timothy Mcdonough, Caroline Gentile, Jianing Liu, Michelle Turner, Carol Denny, Kevin Felice, Misty Green, Stephanie Scarberry, Saad Abu-Saleh, Beatrice Nefussy, Debbie Hastings, Sangri Kim, Blake Swihart, Ximena Arcila-Londono, Daniel S Newman, Michael Silverman, Angela Genge, Kristiana Salmon, Lauren Elman, Leo Mccluskey, Kelly Almasy, Marc Gotkine, Kimberly Goslin, Arlena Cummings, Eli K Edwards, Michael Rivner, Kristy Bouchard, Brandy Quarles, Justin Kwan, Matthew Jaffa, Robert Baloh, Peggy Allred, David Walk, Samuel Maiser, Georgios Manousakis, Valerie Ferment, J Americo M Fernandes, Pariwat Thaisetthawatkul, Deborah Heimes, Melissa Phillips, Laura Sams, Melissa Kahler, Alecia Corcoran, Daniel G Larriviere, Sadie Chotto, and Gracy Juba
Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study., Abhishek Pratap, Daniel Grant, Ashok Vegesna, Meghasyam Tummalacherla, Stanley Cohan, Chinmay Deshpande, Lara Mangravite, and Larsson Omberg
Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND., P Repovic, Derrick Robertson, Kiren Kresa-Reahl, Stanley Cohan, Ray Su, Robin Avila, Irene Koulinska, and Jason P Mendoza
Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry., Tamela Stuchiner, Lindsay Lucas, Elizabeth Baraban, Kateri Spinelli, Chiayi Chen, Alden Smith, Lobat Hashemi, and Stanley Cohan
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM., Mitzi J Williams, Lilyana Amezcua, Annette Okai, Darin T Okuda, Stanley Cohan, Ray Su, Becky Parks, Jason P Mendoza, James B Lewin, and Cynthia C Jones
Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis., Qi Wu, Elizabeth A Mills, Qin Wang, Catherine A Dowling, Caitlyn Fisher, Britany Kirch, Steven K Lundy, David A Fox, Yang Mao-Draayer, AMS04 Study Group, James Bowden, and Stanley Cohan
Submissions from 2019
Regional Stroke Program Coordinator NurseStandardize EMS Feedback Utilizing Kurt Lewin’s Change Model, Molly Archer, Megan Fuller, Kailey Cox, and Natalie Swearingen
Outcomes and Characteristics of Large Vessel Occlusion Patients in a Multi-Hospital System with National Institute of Health Stroke Scale (NIHSS) ≤ 5 Treated with Endovascular Thrombectomy vs Medical Management, Steven Augustine, Lindsay Lucas, Elizabeth Baraban, and Jason Tarpley
Outcomes Of Large Vessel Occlusion Patients In A Multi-hospital System With Nihss<6 Treated With Endovascular Thrombectomy vs Medical>Management, Steven Augustine, Jason Tarpley, Lindsay Lucas, and Elizabeth Baraban
Impact of History of Depression Treatment on Stroke Outcomes, Elizabeth Baraban and L Lucas
Increase in Video Evaluations but Not Complications Over Time in a Large Stroke Network, Archit Bhatt, Elizabeth Baraban, Leslie Corless, and Lindsay Lucas
Better functional outcomes in patients treated versus treated for mild stroke, Bridget Carnahan, Leslie Corless, Lindsay Lucas, Elizabeth Baraban, and Lisa Yanase
Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy., Stanley Cohan, Keith Edwards, Lindsay Lucas, Tiffany Gervasi-Follmar, Judy O'Connor, Jessica Siuta, Vineetha Kamath, Lore Garten, Chiayi Chen, James Thomas, Kyle E Smoot, Kiren Kresa-Reahl, and Kateri Spinelli
Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis., Stanley Cohan, Elisabeth B Lucassen, Meghan C Romba, and Stefanie N Linch
Standardized Code Stroke Inpatient Activation Process Resulted in Consistent Acute Stroke Evaluation Times Regardless of Primary Problem or Patient Location, Kailey Cox, Brandan Sheets, Alyx Lesko, Lindsay Lucas, Ronda Chandler, and Elizabeth Baraban
Acute ischemic stroke in the younger population: Are they being treated fast enough?, Sherri Friedrich, Leslie Corless, Lindsay Lucas, and Elizabeth Baraban
Development of Continuous Quality Improvement in a Telestroke Network, Alyx Lesko, Leslie Corless, Claudia Gaede, Elizabeth Baraban, Lindsay Lucas, and Lisa Yanase
Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes., Jinny Min, Stanley Cohan, Enrique Alvarez, Jacob Sloane, J Theodore Phillips, Anneke van der Walt, Irene Koulinska, Fang Fang, Catherine Miller, and Andrew Chan
Achieving door-to-needle times in under 30 minutes at a community hospital utilizing the concept of stroke team "Quarterback", Renee Ovando, Michelle Phillips, Elizabeth Baraban, and Jason Tarpley
A Propensity-matched Analysis of Outcomes for Patients with M2 Branch Occlusions at Endovascular Stroke Centers, R Ovando, R Lucas, Elizabeth Baraban, and Jason Tarpley
Utilization, safety, and tolerability of ocrelizumab: year 2 data from the Providence Ocrelizumab Registry, Kyle E Smoot
Clinical Experience with the Utilization of Dimethyl Fumarate in Patients with Relapsing MS: 5-year Results on Discontinuation and Treatment Outcomes, Kyle E Smoot, Chiayi Chen, tamela stuchiner, Lindsay Lucas, Lois Grote, Meghan C Romba, Elisabeth Lucassen, Kiren Kresa-Reahl, and Stanley Cohan
Evaluating the Efficacy and Safety of Transitioning Patients from Natalizumab to Ocrelizumab (OCTAVE), Kyle E Smoot, Kiren Kresa-Reahl, P Repovic, Jessica Craddock, Chiayi Chen, Lindsay Lucas, Tiffany Gervasi-Follmar, and Stanley Cohan
Impact of Early Mobilization on 90-Day Outcomes in Thrombectomy Patients, tamela stuchiner, Diane Clark, Lindsay Lucas, John Robison, and Lisa Yanase
No difference in quality of life (QoL) among people who switched from injectable to oral disease modifying treatment (DMT) compared to those who stayed on injectable in a community cohort: a propensity score matched (PSM) analysis, tamela stuchiner, Lindsay Lucas, Elizabeth Baraban, Chiayi Chen, and Stanley Cohan
Reported Quality of Life in those on High Efficacy Compared to First Line Disease Modifying Therapies in a Community Cohort, tamela stuchiner, Lindsay Lucas, Elizabeth Baraban, Chiayi Chen, and Stanley Cohan
Cost Analysis of Implementing Standardized Stroke Patient Education Materials in a Large Five State Health System, Natalie Swearingen, Leslie Corless, Jessica Swann, Kailey Cox, Diane Lada, and Elizabeth Baraban
Large Five State Health System Standardizes Stroke Patient Education while Significantly Improving Health Literacy, Natalie Swearingen, Leslie Corless, Jessica Swann, Kailey Cox, Diane Lada, and Elizabeth Baraban
Complications from IV Alteplase in Mild Stroke Patients in a Multi-state Health System, Lisa Yanase, Lindsay Lucas, Leslie Corless, and Elizabeth Baraban
Post-IV Alteplase Hemorrhage Rates in Early vs. Delayed Treatment Window in a Multi-State Health System, Lisa Yanase, tamela stuchiner, Lindsay Lucas, Leslie Corless, and Elizabeth Baraban
Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study., Robert Zivadinov, Kiren Kresa-Reahl, Bianca Weinstock-Guttman, Keith Edwards, Chakkarin Burudpakdee, Niels Bergsland, Michael G Dwyer, Bhupendra Khatri, Karthinathan Thangavelu, Jeffrey Chavin, Matt Mandel, and Stanley Cohan
Implementation of Coordinated Telestroke Program in an Urban Setting Improves Acute Stroke Care, John Zurasky, Leslie Corless, Lindsay Lucas, and Elizabeth Baraban
Submissions from 2018
Initial presenting stroke symptoms impact treatment timeline among ischemic stroke patients, Elizabeth Baraban, Lindsay Lucas, and Archit Bhatt
Impact of Comorbidity and DMT Use on Disability Status by DMT Group in Participants in the Pacific Northwest MS Registry, Elizabeth Baraban, tamela stuchiner, Lindsay Lucas, Chiayi Chen, Anthony Ranno, Alden Smith, and Stanley Cohan
Impact of Comorbidity and DMT Use on Disability Status by DMT Group in Participants in the Pacific Northwest MS Registry, Elizabeth Baraban, T Stuchiner, L Lucas, C Chen, A Ranno, A Smith, and SL Cohan
Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study., Ralph Hb Benedict, Stanley Cohan, Sharon G Lynch, Katherine Riester, Ping Wang, Wanda Castro-Borrero, Jacob Elkins, and Guido Sabatella
Impact of ocrelizumab on cognition on patients with increased risk of developing progressive disease., Ralph H. Benedict, Jerome de Seze, Stephen L. Hauser, Ludwig Kappos, Jerry S. Wolinsky, Hanzhe Sheng, Shibeshih Belachew, Laura Julian, Asish Pradham, Fred Lublin, and Stanley Cohan
Addressing the targeting range of the ABILHAND-56 in relapsing-remitting multiple sclerosis: A mixed methods psychometric study., Sophie Cleanthous, Sara Strzok, Farrah Pompilus, Stefan Cano, Patrick Marquis, Stanley Cohan, Myla D Goldman, Kiren Kresa-Reahl, Jennifer Petrillo, Carmen Castrillo-Viguera, Diego Cadavid, and Shih-Yin Chen
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)., Stanley L Cohan, Harold Moses, Jonathan Calkwood, Carlo Tornatore, Chris LaGanke, Kyle E Smoot, Venkata Meka, Macaulay Okwuokenye, Christophe Hotermans, Jason P Mendoza, Monica K Mann, and Leslie A Meltzer
Healthcare Utilization and Cost Outcomes for a Multicenter First Seizure and New Onset Epilepsy Clinic, Emily Hudson, Alyx Lesko, Lindsay Lucas, Elizabeth Baraban, Julia Toub, Matt Evans, and Evan J Fertig
Abstract WP348: Stroke Nurse Navigator: Feasibility, Implementation and Early Impact at a Comprehensive Stroke Center, Darren T. Larsen, Kailey Cox, Natalie Swearingen, and Amit Kansara
IV thrombolytic stroke treatment in the 3-4.5 hour time window: Practice diverges from guidelines, Ted Lowenkopf, Leslie Corless, Lindsay Lucas, and Elizabeth Baraban
Effects of opicinumab on patient reported outcomes in participants with relapsing multiple sclerosis: A post-hoc analysis of the phase II Synergy study, Jennifer Petrillo, Stanley Cohan, Carmen Castrillo-Viguera, Ih Chang, Yihong Chai, Shih-Yen Chen, and Bing Zhu
Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center., Kyle E Smoot, Kateri Spinelli, Tamela Stuchiner, Lindsay Lucas, Chiayi Chen, Lois Grote, Elizabeth Baraban, Kiren Kresa-Reahl, and Stanley Cohan
